Clinical Trials / Research Studies

Other Solid Tumors Research Studies

< Back to Young Adult Cancer Research Studies Page

Solid Tumors Plexiform Neurofibroma

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (RENEU)

  • Ages: 2 years and older

This study evaluates PD-0325901 in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas (PNs). All participants will receive PD-0325901. Neurofibromas are benign peripheral nerve sheath tumors, which are classified as plexiform neurofibromas (PNs) ...More

Contact Us

Contact us.

To learn more about available clinical trials related to solid tumors, contact us at cancer@cchmc.org or 513-636-2799.

Related Studies